15 states sue Trump administration over changes to U.S. vaccine schedule
Source: SeekingAlpha
2026-02-25 07:19:21 ET
More on Pfizer, Merck, etc.
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- GSK to acquire Canada's 35Pharma for $950M in cash
- Merck shares advanced for seven consecutive sessions
Read the full article on Seeking Alpha
For further details see:
15 states sue Trump administration over changes to U.S. vaccine schedule
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
1.4% G/L:
$54.50 Last:
3,621,646 Volume:
$55.0309 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
